Genmab has named Matt Kiely as General Manager for the UK
Genmab has named Matt Kiely as General Manager for the United Kingdom, marking a key step in its European commercial expansion. The appointment supports the company’s mission to deliver antibody-based medicines to more patients with cancer.
Founded in Copenhagen in 1999, Genmab specialises in antibody science and operates internationally. The UK appointment reflects its strategy to build a stronger presence across Europe and prepare for future product launches.
Matt joins Genmab with over 20 years of global pharmaceutical…